An overview of cdc2-like kinase 1 (Clk1) inhibitors and their therapeutic indications.
Saved in:
| Title: | An overview of cdc2-like kinase 1 (Clk1) inhibitors and their therapeutic indications. |
|---|---|
| Authors: | ElHady AK; Department of Organic and Pharmaceutical Chemistry, School of Life and Medical Sciences, University of Hertfordshire Hosted by Global Academic Foundation, New Administrative Capital, Cairo, Egypt.; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt., El-Gamil DS; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt.; Department of Chemistry, Faculty of Pharmacy, Ahram Canadian University, Cairo, Egypt., Abadi AH; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt., Abdel-Halim M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt., Engel M; Department of Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbrücken, Germany. |
| Source: | Medicinal research reviews [Med Res Rev] 2023 Mar; Vol. 43 (2), pp. 343-398. Date of Electronic Publication: 2022 Oct 19. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 8103150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1128 (Electronic) Linking ISSN: 01986325 NLM ISO Abbreviation: Med Res Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
